Журнал "Креативная хирургия и онкология" №3 2010

92ОБЗОР ЛИТЕРАТУРЫКреативная хирургия и онкология37. Nakashima T., Kondoh S., Kitoh H. et al. Vascularendothelial growth factorC expression in human gallbladdercancer and its relationship to lymph node metastasis// Int J Mol Med. – 2003. – №11. – Р. 33-39.38. Nathanson S.D. Insights into the mechanismsof lymph node metastasis // Cancer. – 2003. – Vol. 98.– P. 413-423.39. Pepper M.S., Tille J.C., Nisato R., Skobe M. Lymphangiogenesisand tumor metastasis // Cell TissueRes. – 2003. – Vol. 314. – P. 167-177.40. Renyi-Vamos F., Tovari J., Fillinger J. et al. Lymphangiogenesiscorrelates with lymph node metastasis,prognosis, and angiogenic phenotype in humannonsmall cell lung cancer // Clin Cancer Res. – 2005.- №11. - Р. 7344-7353.41. Rissanen T.T., Markkanen J.E., Gruchala M. etal. VEGFD is the strongest angiogenic and lymphangiogeniceffector among VEGFs delivered into skeletalmuscle via adenoviruses // Circ Res. – 2003. – Vol. 92.– P. 1098-1106.42. Salameh A., Galvagni F., Bardelli M. et al. Directrecruitment of CRK and GRB2 to VEGFR3 induces proliferation,migration, and survival of endothelial cellsthrough the activation of ERK, AKT, and JNK pathways// Blood. – 2005. – Vol. 106. – P. 3423-3431.43. Scheele J., Stangi R., Altendorf-Hofmann A.Hepatic metastases from colorectal carcinoma: impactof surgical resection on the natural history // Br J Surg.– 1990. – Vol. 77. – P. 1241–1246.44. Schoppmann S.F., Birner P., Stockl J. et al.Tumorassociated macrophages express lymphatic endothelialgrowth factors and are related to peritumorallymphangiogenesis // Am J Pathol. – 2002. – Vol. 161.– P. 947-56.45. Shields J.D., Fleury M.E., Yong C. et al. Autologouschemotaxis as a mechanism of tumor cell homingto lymphatics via interstitial flow and autocrine CCR7signaling // Cancer Cell. – 2007. - №11. - Р. 526-538.46. Skobe M., Hawighorst T., Jackson D.G. et al.Induction of tumor lymphangiogenesis by VEGFC promotesbreast cancer metastasis // Nat Med. – 2001.- №7. – Vol. 192-198.47. Stacker S.A., Hughes R.A., Williams R.A., AchenM.G. Current strategies for modulating lymphangiogenesissignalling pathways in human disease // CurrMed Chem. - 2006. - №13. – Р. 783-792.48. Stacker SA, Caesar C, Baldwin ME, et al. Vascularendothelial growth factorD promotes the metastaticspread of cancer via the lymphatics // Nature Med.– 2001. - № 7. – Р. 186-191.49. Stefansson I.M., Salvesen H.B., Akslen L.A.Vascular proliferation is important for clinical progressof endometrial cancer // Cancer Res. – 2006. – Vol.66. – P. 3303-3309.50. Straume O., Jackson D.G., Akslen L.A. Independentprognostic impact of lymphatic vessel densityand presence of lowgrade lymphangiogenesis incutaneous melanoma // Clin Cancer. – 2003. - № 9.– Р. 250–256.51. Taipale J., Makinen T., Arighi E. et al. Vascularendothelial growth factor receptor3 // Curr Top MicrobiolImmunol. – 1999. - Vol. 237. – P. 85–96.52. Takeuchi H., Fujimoto A., Tanaka M. et al. CCL21chemokine regulates chemokine receptor CCR7 bearingmalignant melanoma cells // Clin Cancer Res. - 2004.- №10. - Р. 2351–2358.53. Takeuchi H., Kitajima M., Kitagawa Y. Sentinellymph node as a target of molecular diagnosis of lymphaticmicrometastasis and local immunoresponse tomalignant cells // Cancer Sci. – 2008. – Vol. 99. - P.441–450.54. Tamura M., Oda M., Tsunezuka Y. et al. ChestCT and serum vascular endothelial growth factorC levelto diagnose lymph node metastasis in patients with primarynonsmall cell lung cancer // Chest. – 2004. – Vol.126. – P. 342–346.55. The Lymphatic Continuum Revisited. RocksonSG: Ed. Ann N Y Acad Sci, 2008. – Vol. 1131. - 243 p.56. Van den Eynden G.G., Van der Auwera I., VanLaere S.J. et al. Induction oflymphangiogenesis in andaround axillary lymph node metastases of patients withbreast cancer // Br J Cancer. – 2006. – Vol. 95. – P.1362–1366.57. Van der Auwera I., Cao Y., Tille J.C. et al. Firstinternational consensus on the methodology of lymphangiogenesisquantification in solid human tumours// Br J Cancer. – 2006. – Vol. 95. – P. 1611–1125.58. Vihinen P.P., Hilli J., Vuoristo M.S. et al. SerumVEGFC is associated with metastatic site in patients withmalignant melanoma // Acta Oncol. - 2007. – Vol. 46.– P. 678–684.59. Vlahakis N.E., Young B.A., Atakilit A., SheppardD. The lymphangiogenic vascular endothelial growthfactors VEGFC and D are ligands for the integrinalpha9beta1 // J Biol Chem. – 2005. – Vol. 280. – P.4544–4552.60. Wang T.B., Deng M.H., Qiu W.S., Dong W.G.et al. Association of serum vascular endothelial growthfactorC and lymphatic vessel density with lymph nodemetastasis and prognosis of patients with gastriccancer // World J Gastroenterol. - 2007. – Vol. 28.– P. 1794–1798.61. Whitehurst B., Flister M.J., Bagaitkar J. et al.AntiVEGFA therapy reduces lymphatic vessel densityand expression of VEGFR3 in an orthotopic breasttumor model // Int J Cancer. – 2007. – Vol. 121. – P.2181–2191.62. Wong S.Y., Haack H., Crowley D. et al. Tumorsecretedvascular endothelial growth factorC is necessaryfor prostate cancer lymphangiogenesis, but lymphangiogenesisis unnecessary for lymph node metastasis //Cancer Res. – 2005. – Vol. 65. - Р. 9789–9798.63. Woo S.U., Bae J.W., Yang J.H. et al. Overexpressionof interleukin10 in sentinel lymph node with breast cancer// Ann Surg Oncol. – 2007. - №14. – Р. 3268–3273.64. Yu X.M., Lo C.Y., Lam A.K. et al. Serum vascularendothelial growth factor C correlates with lymph nodemetastases and highrisk tumor profiles in papillarythyroid carcinoma // Ann Surg. – 2008. – Vol. 247. –P. 483–489.Перепечатано с разрешения автораИсточник: Онкология. - 2009. - Т. 11.- №2. - С. 93-102.